Updates are available Correction dated 2023-06-01

Article History

Received: 20 June 2022

Accepted: 18 April 2023

First Online: 9 May 2023

Change Date: 1 June 2023

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s13063-023-07370-5

Declarations

:

: The study and protocol are developed according to the Declaration of Helsinki guidelines. The protocol has been approved by the institute ethics committee, Integral University (IIAHSR/DO/PT/2022/23) and Composite Regional Centre for Skill Development, Rehabilitation, and Empowerment of Persons with Disabilities (CRCL/Ph.D.Data Collection/2021–22/1556) and registered under access code CTRI/2022/03/041143 in the Clinical Trial Registry of India (CTRI). Date of registration: 16 March 22.This protocol, the template informed consent forms contained in the InternalRef removed (local language and English versions), participant education and recruitment materials, and other requested documents will be reviewed and approved by the institutional review boards/ethical committees of both study centers for scientific content and compliance with applicable human subjects’ regulations. The clinical trial registry and the ethics committee will be notified of any modifications to the trial protocol. No data monitoring committee has been established because there are no expected adverse outcomes other than possible brief soreness after the exercises. After initial assessment and approval, the local ethical committees will conduct a minimum annual review of the protocol. The investigator will provide safety and progress updates to the ethical committees at least once per year and within 3 months of the study’s termination or conclusion at their site.Participation in the study is voluntary, and no incentives/rewards will be offered for participation in the study. The invitation to participate will briefly state the background and objectives of the study along with the distribution of results plan. Participants who provide their consent will be allowed to participate in the study. Those who decline to participate will be excluded from further process and will have a choice to state the reason for declining. The prospective participants will have access to the e-mail ID and phone number of the first/corresponding author should they wish to have any questions answered. Participants are free to exit the study at any point of time.

: All authors provided their consent for publication.

: The authors declare that they have no competing interests.